Atlas Blockchain Announces Conditional Approval of Transaction with Isracann Biosciences Inc.

Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) wishes to advise that further to its news release dated May 21, 2019, the Canadian…

Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A49) (OTCPINK: ATLEF) wishes to advise that further to its news release dated May 21, 2019, the Canadian Securities Exchange (the “CSE”) has conditionally accepted its proposed transaction with Isracann Biosciences Inc., which is considered a fundamental change under the policies of the CSE. Upon successful completion of […]

The post Atlas Blockchain Announces Conditional Approval of Transaction with Isracann Biosciences Inc. appeared first on Technical420.

Leave a Reply

Your email address will not be published. Required fields are marked *